These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34013213)

  • 41. In Vivo CRISPR Screen Identifies TgWIP as a Toxoplasma Modulator of Dendritic Cell Migration.
    Sangaré LO; Ólafsson EB; Wang Y; Yang N; Julien L; Camejo A; Pesavento P; Sidik SM; Lourido S; Barragan A; Saeij JPJ
    Cell Host Microbe; 2019 Oct; 26(4):478-492.e8. PubMed ID: 31600500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR/Cas9 and glycomics tools for
    Gas-Pascual E; Ichikawa HT; Sheikh MO; Serji MI; Deng B; Mandalasi M; Bandini G; Samuelson J; Wells L; West CM
    J Biol Chem; 2019 Jan; 294(4):1104-1125. PubMed ID: 30463938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virulence-related gene wx2 of Toxoplasma gondii regulated host immune response via classic pyroptosis pathway.
    Ma Z; Li Z; Jiang R; Li X; Yan K; Zhang N; Lu B; Huang Y; Dibo N; Wu X
    Parasit Vectors; 2022 Dec; 15(1):454. PubMed ID: 36471417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts.
    Garfoot AL; Wilson GM; Coon JJ; Knoll LJ
    BMC Genomics; 2019 Nov; 20(1):859. PubMed ID: 31726967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigative study on the role of the Toxo 5699 gene in the Toxoplasma gondii lytic cycle using the CRISPR/Cas9 system.
    De Silva JR; Ching XT; Lau YL
    Trop Biomed; 2020 Jun; 37(2):324-332. PubMed ID: 33612802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated bioinformatic and targeted deletion analyses of the SRS gene superfamily identify SRS29C as a negative regulator of Toxoplasma virulence.
    Wasmuth JD; Pszenny V; Haile S; Jansen EM; Gast AT; Sher A; Boyle JP; Boulanger MJ; Parkinson J; Grigg ME
    mBio; 2012 Nov; 3(6):. PubMed ID: 23149485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact.
    Ishizaki T; Hernandez S; Paoletta MS; Sanderson T; Bushell ESC
    Biochem Soc Trans; 2022 Jun; 50(3):1069-1079. PubMed ID: 35621119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of innate immunity by Toxoplasma gondii virulence effectors.
    Hunter CA; Sibley LD
    Nat Rev Microbiol; 2012 Nov; 10(11):766-78. PubMed ID: 23070557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy.
    Reid AJ; Vermont SJ; Cotton JA; Harris D; Hill-Cawthorne GA; Könen-Waisman S; Latham SM; Mourier T; Norton R; Quail MA; Sanders M; Shanmugam D; Sohal A; Wasmuth JD; Brunk B; Grigg ME; Howard JC; Parkinson J; Roos DS; Trees AJ; Berriman M; Pain A; Wastling JM
    PLoS Pathog; 2012; 8(3):e1002567. PubMed ID: 22457617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The ROP18 and ROP5 gene allele types are highly predictive of virulence in mice across globally distributed strains of Toxoplasma gondii.
    Shwab EK; Jiang T; Pena HF; Gennari SM; Dubey JP; Su C
    Int J Parasitol; 2016 Feb; 46(2):141-6. PubMed ID: 26699401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii.
    Behnke MS; Dubey JP; Sibley LD
    Annu Rev Microbiol; 2016 Sep; 70():63-81. PubMed ID: 27359216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transepithelial migration by Toxoplasma.
    Barragan A; Hitziger N
    Subcell Biochem; 2008; 47():198-207. PubMed ID: 18512353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophages as a battleground for toxoplasma pathogenesis.
    Murray PJ
    Cell Host Microbe; 2011 Jun; 9(6):445-7. PubMed ID: 21669391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii.
    Fox BA; Bzik DJ
    Nature; 2002 Feb; 415(6874):926-9. PubMed ID: 11859373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toxoplasma MIC2 is a major determinant of invasion and virulence.
    Huynh MH; Carruthers VB
    PLoS Pathog; 2006 Aug; 2(8):e84. PubMed ID: 16933991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of eukaryotic initiation factor-2{alpha} promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii.
    Joyce BR; Queener SF; Wek RC; Sullivan WJ
    Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17200-5. PubMed ID: 20855600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental approaches to understanding virulence in toxoplasmosis.
    Sibley LD; Mordue D; Howe DK
    Immunobiology; 1999 Dec; 201(2):210-24. PubMed ID: 10631570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identifying synthetic lethal targets using CRISPR/Cas9 system.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protocol for genome-wide CRISPR knockout screens of bacterial cytotoxins in HeLa cells.
    Yang Q; Zhou Y; He L; Zhang Y; Tao L
    STAR Protoc; 2022 Sep; 3(3):101595. PubMed ID: 35928004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computational pipeline for designing guide RNAs for mismatch-CRISPRi.
    van Gestel J; Hawkins JS; Todor H; Gross CA
    STAR Protoc; 2021 Jun; 2(2):100521. PubMed ID: 34027480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.